Gary R Lichtenstein. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/economicsAntibodies, Monoclonal/therapeutic useCrohn Disease/drug therapyCrohn Disease/economicsDrug CostsGastrointestinal Agents/economicsGastrointestinal Agents/therapeutic useHumansInfliximab
Substances: See more » Antibodies, MonoclonalGastrointestinal AgentsInfliximab
Year: 2004 PMID: 15300614 DOI: 10.1053/j.gastro.2004.06.043
Source DB: PubMed Journal: Gastroenterology ISSN: 0016-5085 Impact factor: 22.682